Social Media Has Come of Age
In the past few years we have become acutely aware of the use of Internet social media websites serving as sources of information about everything from family reunions to recipie sharing. There is no doubt that social media has a place in clinical trial enrollment and ICTS has been at the forefront of social media use for this purpose.
As Erik Qualman states in his book, SocialnomicsTM, social media is unquestionably a powerful communication entity. There is a video on our website produced by Erik that is a true eye opener reagrding the impact of social media. You can view Erik's video and a link to his book by clicking this link http://icts.us/page/socialnomics
Although the FDA is currently examining use of social media in pharmaceutical marketing it is the ultimate responsibility of the IRB/EC for a study to monitor use of social media for clinical trial enrollment. ICTS has developed social media use SOPs that have helped our clients get clearance for social media blogging as part of an integrated enrollment campaign. You can contact Michael Ohrwashel, VP of business development for more information. mbo@icts.us
See how we have strategically helped other clinical trials. Case Studies





Reader Comments
There are no comments yet. Be the first to create one!
Leave a Comment